Click for best price
Follicular Lymphoma Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 1760.6 million
|
Forecast Market size by 2029 |
US$ 2842.4 million
|
| Growth Rate |
CAGR of 7.1% |
Number of Pages |
69 Pages |
Follicular lymphoma is a cancer that affects white blood cells called lymphocytes. There are two types of lymphomas: Hodgkin's and non-Hodgkin's, based on the kind of white blood cell they affect. Follicular lymphoma is a non-Hodgkin's lymphoma.Drugs for Follicular lymphoma are Anti-CD20 mAbs, Chemotherapy Agents, Kinase Inhibitor, etc.
This report aims to provide a comprehensive presentation of the global market for Follicular Lymphoma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Follicular Lymphoma Drugs. This report contains market size and forecasts of Follicular Lymphoma Drugs in global, including the following market information:
Global Follicular Lymphoma Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Follicular Lymphoma Drugs market was valued at US$ 1760.6 million in 2022 and is projected to reach US$ 2842.4 million by 2029, at a CAGR of 7.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core follicular lymphoma drugs players include Roche, Teva and Bayer etc. The Top3 companies hold a share about 57%. North America is the largest market, with a share about 58%, followed by Europe and Asia Pacific with the share about 21% and 20%.
We surveyed the Follicular Lymphoma Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Follicular Lymphoma Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Follicular Lymphoma Drugs Market Segment Percentages, by Type, 2022 (%)
Anti-CD20 mAbs
Chemotherapy Agents
Kinase Inhibitor
Others
Global Follicular Lymphoma Drugs Market, by Administration Route, 2018-2023, 2024-2029 ($ millions)
Global Follicular Lymphoma Drugs Market Segment Percentages, by Administration Route, 2022 (%)
Injection
Oral
Global Follicular Lymphoma Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Follicular Lymphoma Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Follicular Lymphoma Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Follicular Lymphoma Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
Epizyme
Eisai
Acrotech Biopharma
Teva
Eagle Pharmaceuticals
MundiPharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Follicular Lymphoma Drugs, market overview.
Chapter 2: Global Follicular Lymphoma Drugs market size in revenue.
Chapter 3: Detailed analysis of Follicular Lymphoma Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by administration route, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Follicular Lymphoma Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Follicular Lymphoma Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 1760.6 million
|
| Forecast Market size by 2029 |
US$ 2842.4 million
|
| Growth Rate |
CAGR of 7.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Follicular Lymphoma Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Administration Route
1.3 Global Follicular Lymphoma Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Follicular Lymphoma Drugs Overall Market Size
2.1 Global Follicular Lymphoma Drugs Market Size: 2022 VS 2029
2.2 Global Follicular Lymphoma Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Follicular Lymphoma Drugs Players in Global Market
3.2 Top Global Follicular Lymphoma Drugs Companies Ranked by Revenue
3.3 Global Follicular Lymphoma Drugs Revenue by Companies
3.4 Top 3 and Top 5 Follicular Lymphoma Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Follicular Lymphoma Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Follicular Lymphoma Drugs Players in Global Market
3.6.1 List of Global Tier 1 Follicular Lymphoma Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Follicular Lymphoma Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Follicular Lymphoma Drugs Market Size Markets, 2022 & 2029
4.1.2 Anti-CD20 mAbs
4.1.3 Chemotherapy Agents
4.1.4 Kinase Inhibitor
4.1.5 Others
4.2 By Type - Global Follicular Lymphoma Drugs Revenue & Forecasts
4.2.1 By Type - Global Follicular Lymphoma Drugs Revenue, 2018-2023
4.2.2 By Type - Global Follicular Lymphoma Drugs Revenue, 2024-2029
4.2.3 By Type - Global Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
5 Sights by Administration Route
5.1 Overview
5.1.1 By Administration Route - Global Follicular Lymphoma Drugs Market Size, 2022 & 2029
5.1.2 Injection
5.1.3 Oral
5.2 By Administration Route - Global Follicular Lymphoma Drugs Revenue & Forecasts
5.2.1 By Administration Route - Global Follicular Lymphoma Drugs Revenue, 2018-2023
5.2.2 By Administration Route - Global Follicular Lymphoma Drugs Revenue, 2024-2029
5.2.3 By Administration Route - Global Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Follicular Lymphoma Drugs Market Size, 2022 & 2029
6.2 By Region - Global Follicular Lymphoma Drugs Revenue & Forecasts
6.2.1 By Region - Global Follicular Lymphoma Drugs Revenue, 2018-2023
6.2.2 By Region - Global Follicular Lymphoma Drugs Revenue, 2024-2029
6.2.3 By Region - Global Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Follicular Lymphoma Drugs Revenue, 2018-2029
6.3.2 US Follicular Lymphoma Drugs Market Size, 2018-2029
6.3.3 Canada Follicular Lymphoma Drugs Market Size, 2018-2029
6.3.4 Mexico Follicular Lymphoma Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Follicular Lymphoma Drugs Revenue, 2018-2029
6.4.2 Germany Follicular Lymphoma Drugs Market Size, 2018-2029
6.4.3 France Follicular Lymphoma Drugs Market Size, 2018-2029
6.4.4 U.K. Follicular Lymphoma Drugs Market Size, 2018-2029
6.4.5 Italy Follicular Lymphoma Drugs Market Size, 2018-2029
6.4.6 Russia Follicular Lymphoma Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Follicular Lymphoma Drugs Market Size, 2018-2029
6.4.8 Benelux Follicular Lymphoma Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Follicular Lymphoma Drugs Revenue, 2018-2029
6.5.2 China Follicular Lymphoma Drugs Market Size, 2018-2029
6.5.3 Japan Follicular Lymphoma Drugs Market Size, 2018-2029
6.5.4 South Korea Follicular Lymphoma Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Follicular Lymphoma Drugs Market Size, 2018-2029
6.5.6 India Follicular Lymphoma Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Follicular Lymphoma Drugs Revenue, 2018-2029
6.6.2 Brazil Follicular Lymphoma Drugs Market Size, 2018-2029
6.6.3 Argentina Follicular Lymphoma Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Follicular Lymphoma Drugs Revenue, 2018-2029
6.7.2 Turkey Follicular Lymphoma Drugs Market Size, 2018-2029
6.7.3 Israel Follicular Lymphoma Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Follicular Lymphoma Drugs Market Size, 2018-2029
6.7.5 UAE Follicular Lymphoma Drugs Market Size, 2018-2029
7 Follicular Lymphoma Drugs Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Follicular Lymphoma Drugs Major Product Offerings
7.1.4 Roche Follicular Lymphoma Drugs Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Follicular Lymphoma Drugs Major Product Offerings
7.2.4 Gilead Sciences Follicular Lymphoma Drugs Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 TG Therapeutics
7.3.1 TG Therapeutics Company Summary
7.3.2 TG Therapeutics Business Overview
7.3.3 TG Therapeutics Follicular Lymphoma Drugs Major Product Offerings
7.3.4 TG Therapeutics Follicular Lymphoma Drugs Revenue in Global Market (2018-2023)
7.3.5 TG Therapeutics Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Follicular Lymphoma Drugs Major Product Offerings
7.4.4 Bayer Follicular Lymphoma Drugs Revenue in Global Market (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Secura Bio
7.5.1 Secura Bio Company Summary
7.5.2 Secura Bio Business Overview
7.5.3 Secura Bio Follicular Lymphoma Drugs Major Product Offerings
7.5.4 Secura Bio Follicular Lymphoma Drugs Revenue in Global Market (2018-2023)
7.5.5 Secura Bio Key News & Latest Developments
7.6 Epizyme
7.6.1 Epizyme Company Summary
7.6.2 Epizyme Business Overview
7.6.3 Epizyme Follicular Lymphoma Drugs Major Product Offerings
7.6.4 Epizyme Follicular Lymphoma Drugs Revenue in Global Market (2018-2023)
7.6.5 Epizyme Key News & Latest Developments
7.7 Eisai
7.7.1 Eisai Company Summary
7.7.2 Eisai Business Overview
7.7.3 Eisai Follicular Lymphoma Drugs Major Product Offerings
7.7.4 Eisai Follicular Lymphoma Drugs Revenue in Global Market (2018-2023)
7.7.5 Eisai Key News & Latest Developments
7.8 Acrotech Biopharma
7.8.1 Acrotech Biopharma Company Summary
7.8.2 Acrotech Biopharma Business Overview
7.8.3 Acrotech Biopharma Follicular Lymphoma Drugs Major Product Offerings
7.8.4 Acrotech Biopharma Follicular Lymphoma Drugs Revenue in Global Market (2018-2023)
7.8.5 Acrotech Biopharma Key News & Latest Developments
7.9 Teva
7.9.1 Teva Company Summary
7.9.2 Teva Business Overview
7.9.3 Teva Follicular Lymphoma Drugs Major Product Offerings
7.9.4 Teva Follicular Lymphoma Drugs Revenue in Global Market (2018-2023)
7.9.5 Teva Key News & Latest Developments
7.10 Eagle Pharmaceuticals
7.10.1 Eagle Pharmaceuticals Company Summary
7.10.2 Eagle Pharmaceuticals Business Overview
7.10.3 Eagle Pharmaceuticals Follicular Lymphoma Drugs Major Product Offerings
7.10.4 Eagle Pharmaceuticals Follicular Lymphoma Drugs Revenue in Global Market (2018-2023)
7.10.5 Eagle Pharmaceuticals Key News & Latest Developments
7.11 MundiPharma
7.11.1 MundiPharma Company Summary
7.11.2 MundiPharma Business Overview
7.11.3 MundiPharma Follicular Lymphoma Drugs Major Product Offerings
7.11.4 MundiPharma Follicular Lymphoma Drugs Revenue in Global Market (2018-2023)
7.11.5 MundiPharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Follicular Lymphoma Drugs Market Opportunities & Trends in Global Market
Table 2. Follicular Lymphoma Drugs Market Drivers in Global Market
Table 3. Follicular Lymphoma Drugs Market Restraints in Global Market
Table 4. Key Players of Follicular Lymphoma Drugs in Global Market
Table 5. Top Follicular Lymphoma Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Follicular Lymphoma Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Follicular Lymphoma Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Follicular Lymphoma Drugs Product Type
Table 9. List of Global Tier 1 Follicular Lymphoma Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Follicular Lymphoma Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Follicular Lymphoma Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Follicular Lymphoma Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Follicular Lymphoma Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Administration Route ? Global Follicular Lymphoma Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Administration Route - Follicular Lymphoma Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Administration Route - Follicular Lymphoma Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Follicular Lymphoma Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Follicular Lymphoma Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Follicular Lymphoma Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Follicular Lymphoma Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Follicular Lymphoma Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Follicular Lymphoma Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Follicular Lymphoma Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Follicular Lymphoma Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Follicular Lymphoma Drugs Product Offerings
Table 32. Roche Follicular Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences Follicular Lymphoma Drugs Product Offerings
Table 36. Gilead Sciences Follicular Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. TG Therapeutics Company Summary
Table 39. TG Therapeutics Follicular Lymphoma Drugs Product Offerings
Table 40. TG Therapeutics Follicular Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. TG Therapeutics Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Follicular Lymphoma Drugs Product Offerings
Table 44. Bayer Follicular Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer Key News & Latest Developments
Table 46. Secura Bio Company Summary
Table 47. Secura Bio Follicular Lymphoma Drugs Product Offerings
Table 48. Secura Bio Follicular Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Secura Bio Key News & Latest Developments
Table 50. Epizyme Company Summary
Table 51. Epizyme Follicular Lymphoma Drugs Product Offerings
Table 52. Epizyme Follicular Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Epizyme Key News & Latest Developments
Table 54. Eisai Company Summary
Table 55. Eisai Follicular Lymphoma Drugs Product Offerings
Table 56. Eisai Follicular Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Eisai Key News & Latest Developments
Table 58. Acrotech Biopharma Company Summary
Table 59. Acrotech Biopharma Follicular Lymphoma Drugs Product Offerings
Table 60. Acrotech Biopharma Follicular Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Acrotech Biopharma Key News & Latest Developments
Table 62. Teva Company Summary
Table 63. Teva Follicular Lymphoma Drugs Product Offerings
Table 64. Teva Follicular Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Key News & Latest Developments
Table 66. Eagle Pharmaceuticals Company Summary
Table 67. Eagle Pharmaceuticals Follicular Lymphoma Drugs Product Offerings
Table 68. Eagle Pharmaceuticals Follicular Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Eagle Pharmaceuticals Key News & Latest Developments
Table 70. MundiPharma Company Summary
Table 71. MundiPharma Follicular Lymphoma Drugs Product Offerings
Table 72. MundiPharma Follicular Lymphoma Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. MundiPharma Key News & Latest Developments
List of Figures
Figure 1. Follicular Lymphoma Drugs Segment by Type in 2022
Figure 2. Follicular Lymphoma Drugs Segment by Administration Route in 2022
Figure 3. Global Follicular Lymphoma Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Follicular Lymphoma Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Follicular Lymphoma Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Follicular Lymphoma Drugs Revenue in 2022
Figure 8. By Type - Global Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
Figure 9. By Administration Route - Global Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Follicular Lymphoma Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
Figure 12. By Administration Route - Global Follicular Lymphoma Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Administration Route - Global Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
Figure 16. US Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
Figure 28. China Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Follicular Lymphoma Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Follicular Lymphoma Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. TG Therapeutics Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Secura Bio Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Epizyme Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Eisai Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Acrotech Biopharma Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eagle Pharmaceuticals Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. MundiPharma Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
